Australien - engelska - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - pantoprazole sodium, quantity: 42.29 mg (equivalent: pantoprazole, qty 40 mg) - injection, powder for - excipient ingredients: - short-term use where oral therapy is not appropriate for the following conditions. 1. symptomatic improvement and healing of gastrointestinal diseases which require a reduction in acid secretion, e.g. duodenal ulcer, gastric ulcer, reflux oesophagitis, gastrointestinal lesions refractory to h2 blockers, zollinger-ellison syndrome. 2. maintenance of healed reflux oesophagitis in patients previously treated for moderate to severe reflux oesophagitis.,note: patients whose gastric or duodenal ulceration is not associated with ingestion of nonsteroidal anti-inflammatory drugs require treatment with antimicrobial agents in addition to anti-secretory drugs, whether on first presentation or recurrence.

Irland - engelska - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - pantoprazole sodium sesquihydrate - gastro-resistant tablet - 20 milligram(s) - proton pump inhibitors; pantoprazole

Irland - engelska - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - pantoprazole sodium sesquihydrate - gastro-resistant tablet - 40 milligram(s) - proton pump inhibitors; pantoprazole

Malta - engelska - Medicines Authority

mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - pantoprazole - gastro-resistant tablet - pantoprazole 20 mg - drugs for acid related disorders

Australien - engelska - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - pantoprazole sodium sesquihydrate, quantity: 45.12 mg (equivalent: pantoprazole, qty 40 mg) - injection, powder for - excipient ingredients: nitrogen - pantoprazole sandoz is indicated for short-term use where oral therapy is not appropriate for the following conditions: 1. symptomatic improvement and healing of gastrointestinal diseases which require a reduction in acid secretion, e.g. duodenal ulcer, gastric ulcer, reflux oesophagitis, gastrointestinal lesions refractory to h2 blockers, zollinger-ellison syndrome. 2. maintenance of healed reflux oesophagitis in patients previously treated for moderate to severe reflux oesophagitis. note: patients who gastric or duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs require treatment with anti-microbial agents in addition to anti-secretory medicines, whether on first presentation or recurrence.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

biocelect pty ltd - japanese encephalitis virus, quantity: 4 pfu - injection, powder for - excipient ingredients: albumin; mannitol; glutamic acid; histidine; sodium chloride; potassium hydroxide; lactose monohydrate; water for injections - imojev is indicated for prophylaxis of japanese encephalitis caused by the japanese encephalitis virus, in individuals from 9 months of age and over.

Irland - engelska - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - pantoprazole - pdr for soln for injection - 40 milligram

Filippinerna - engelska - FDA (Food And Drug Administration)

pan-ject pharmaceuticals corp.; distributor: pan-ject pharmaceuticals corp. - ampicillin sodium , sulbactam sodium - powder for injection - 500mg / 250mg vial

Filippinerna - engelska - FDA (Food And Drug Administration)

pan-ject pharmaceuticals corp.; distributor: pan-ject pharmaceuticals corp. - oxacillin sodium - powder for injection - 500mg

Filippinerna - engelska - FDA (Food And Drug Administration)

pan-ject pharmaceuticals corp.; distributor: pan-ject pharmaceuticals corp. - tranexamic acid - solution for injection (iv) - 100mg/ml (500mg/5ml)